Vicapsys Life Sciences, Inc.
VICP- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001468639
No open-market purchases or sales by Vicapsys Life Sciences, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Holders of 5% or more of VICP
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Vicapsys Life Sciences, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Wildcat Capital Management, LLC | 13G | 18.80%6.07M shares | New | Mar 21, 20251 filing | Mar 21, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
1 Schedule 13D or 13G filing on Vicapsys Life Sciences, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Mar 21, 20256:33 PM ET | Wildcat Capital Management, LLCand 2 others | 13G | 18.80%6.07M shares | New | Apr 20, 2020 | SEC |
Form 144: proposed insider sales
Notices from officers, directors and other affiliates planning to sell Vicapsys Life Sciences, Inc. shares.
No Form 144 notices for Vicapsys Life Sciences, Inc. are on file.